Skip to main content

Table 3 Spinal cord doses in 31 patients who developed Lhermitte’s sign

From: Incidence and predictors of Lhermitte’s sign among patients receiving mediastinal radiation for lymphoma

  Total dose, Spinal cord Location of
Patient ID Gy Dmax Gy (%) Dmax Cord V105%, cm3
1 30.6 33.04 (108) T4–T5 3
2 30.6 28.51 (93) 0
3 30.6 33.98 (111) T3 2.26
4 30.6 29.1 (95) 0
5 30.6 31.84 (104) T5–T6 0
6 30.6 35.81 (117) T3–T8 14.6
7 30.6 31.02 (101) 0
8 30.6 30.10 (98) 0
9 30.6 29.93 (98) 0
10 30.6 34.66 (113) T5 0.5
11 30.6 30.85 (101) 0
12 30.6 31.96 (104) 0
13 30.6 28.06 (92) 0
14 30.6 30.94 (101) 0
15 30.6 34.67 (113) T4–T7 1.1
16 30.6 30.01 (98) 0
17 30.6 32.18 (105) T9 0
18 29.75 31.19 (105) 0
19 30.6 31.72 (104) 0
20 30.6 33.12 (108) T4 0.8
21 30.6 33.06 (108) T4 1.3
22 30.6 37.23 (105) 0
23 30.6 38.78 (108) T6 0.02
24 30.6 36.21 (101) 0
25 37.4 39.34 (105) 0
26 39.6 34.13 (109) T1-T2; T5; T8 0.8
27 41.4 38.69 (93) 0
28 42.0 31.02 (74) 0
29 46.6 39.40 (85) 0
30 41.4 43.51 (105) 0
31 36.0 35.48 (99) 0
  1. D max = maximum point dose